OTC: MRMD · Life Sciences · 4 alerts · CIK 1522767
Share price
$0.0626Close, Nov 16
Market cap
$25.4M
Shares outstanding
406MLatest SEC cover page
Sector
Life Sciences
Industry
Medicinal Chemicals & Botanical ProductsSIC 2833
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Marimed Inc. filings on SEC EDGAR ↗
MariMed Inc. reported revenue of $44.2 million for the third quarter of 2026, a 9% increase year-over-year, though it recorded a net loss of $3.5 million due to high income tax provisions and interest expenses. The company's balance sheet shows $10.4 million in cash and a total of 405,996,010 common shares outstanding as of November 10, 2026.
MariMed Inc. reported record third-quarter 2026 revenue of $44.2 million, a year-over-year increase driven by growth in both wholesale and retail segments. Despite the revenue growth, the company reported a GAAP net loss of $3.5 million as it continues to execute its 'Expand the Brand' strategy and navigate broader market conditions.
Term
Q3 2026
“I’m pleased to report that the momentum we built earlier this year extended through the third quarter. Wholesale and retail revenue both grew sequentially and year over year, and total revenue reached another record for MariMed. Adjusted EBITDA improved from the prior quarter, and we again generated positive cash flow from operations, ending the quarter in our strongest position in more than two years.”